Triple-negative pleomorphic lobular carcinoma and expression of androgen receptor: Personal case series and review of the literature
Fig 2
Survival analysis of invasive PLC patients with invasive pleomorphic lobular carcinoma.
Disease-specific survival (DSS, A–D) and progression-free survival (PFS, E–H) analyses. The DSS was worse in patients with histological grade 3 cancer than in those with histological grade 2 cancer, although there was no significant difference in the PFS rates between the two groups. Other factors, including clinical stage, high Ki-67 labeling index, and non-triple-negative subtype were not related to DSS or PFS.